Gene Silencing of TGFβRII Can Inhibit Glioblastoma Cell Growth

OBJECTIVE: Glioblastoma (GBM) is the most malignant and aggressive type of glioma, associated with a high rate of mortality. The transforming growth factor-β receptor II (TGFβ RII) is involved in glioma initiation and progression. On the other hand, TGFβ RII silencing is critical to the inhibition o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Aval, Farzane Ordoni, Amiri, Shaghayegh Askarian, Azadmehr, Abbas, Oladnabi, Morteza, Saadat, Payam, Ebrahimi, Hadi, Baradaran, Behzad, Mansoori, Behzad, Pourabdolhossein, Fereshteh, Torabian, Pedram, Hajiahmadi, Mahmoud
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6249455/
https://ncbi.nlm.nih.gov/pubmed/30256570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.9.2681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars